Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer

NCT05922930 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer
Ovarian Cancer
Adenocarcinoma

Interventions

DRUG: TROP2-CAR-NK
DRUG: Cyclophosphamide
DRUG: Fludarabine

Sponsor

M.D. Anderson Cancer Center